Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells

The availability of hematopoietic growth factors has greatly facilitated the mobilization and collection of peripheral blood stem cells (PBSC). It was the aim of this double-blind study to compare the PBSC-mobilizing efficacy of recombinant human G-CSF and GM-CSF when administered post-chemotherapy....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hohaus, Stefan (VerfasserIn) , Martin, H. (VerfasserIn) , Waßmann, Barbara (VerfasserIn) , Egerer, Gerlinde (VerfasserIn) , Haus, U. (VerfasserIn) , Färber, L. (VerfasserIn) , Burger, K. J. (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Hoelzer, D. (VerfasserIn) , Haas, Rainer (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 09 October 1998
In: Bone marrow transplantation
Year: 1998, Jahrgang: 22, Heft: 7, Pages: 625-630
ISSN:1476-5365
DOI:10.1038/sj.bmt.1701422
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.bmt.1701422
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/1701422
Volltext
Verfasserangaben:S. Hohaus, H. Martin, B. Wassmann, G. Egerer, U. Haus, L. Färber, K.J. Burger, H. Goldschmidt, D. Hoelzer, and R. Haas

MARC

LEADER 00000caa a2200000 c 4500
001 1923462318
003 DE-627
005 20250717011102.0
007 cr uuu---uuuuu
008 250423s1998 xx |||||o 00| ||eng c
024 7 |a 10.1038/sj.bmt.1701422  |2 doi 
035 |a (DE-627)1923462318 
035 |a (DE-599)KXP1923462318 
035 |a (OCoLC)1528044871 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hohaus, Stefan  |e VerfasserIn  |0 (DE-588)1084809745  |0 (DE-627)848733983  |0 (DE-576)168163020  |4 aut 
245 1 0 |a Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells  |c S. Hohaus, H. Martin, B. Wassmann, G. Egerer, U. Haus, L. Färber, K.J. Burger, H. Goldschmidt, D. Hoelzer, and R. Haas 
264 1 |c 09 October 1998 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.04.2025 
520 |a The availability of hematopoietic growth factors has greatly facilitated the mobilization and collection of peripheral blood stem cells (PBSC). It was the aim of this double-blind study to compare the PBSC-mobilizing efficacy of recombinant human G-CSF and GM-CSF when administered post-chemotherapy. Twenty-six patients with relapsed Hodgkin’s disease were included in the study. Their median age was 31 years (range, 22-59) and 14 patients were males and 12 were females. Patients were pretreated with a median of eight cycles of cytotoxic chemotherapy, while 18 patients had undergone extended field irradiation. The patients received dexamethasone 24 mg days 1-7, melphalan 30 mg/m2 day 3, BCNU 60 mg/m2 day 3, etoposide 75 mg/m2 days 4-7, Ara-C 100 mg/m2 twice daily days 4-7 (Dexa-BEAM). Twelve patients were randomized to receive 5 μg/kg/day G-CSF and 14 patients to receive 5 μg/kg/day GM-CSF, both administered subcutaneously starting on day 1 after the end of Dexa-BEAM. Primary endpoints of the study were the number of CD34+ cells harvested per kg body weight on the occasion of six consecutive leukaphereses and the time needed for hematological reconstitution following autografting. Twenty-one patients completed PBSC collection, and six patients of the G-CSF group and nine of the GM-CSF group were autografted. No difference was observed with respect to the median yield of CFU-GM and CD34+ cells: 32.5 × 104/kg vs 31.3 × 104/kg CFU-GM, and 7.6 × 106/kg vs 5.6 × 106/kg CD34+ cells, for G-CSF and GM-CSF, respectively (U test, P = 0.837 and 0.696). High-dose chemotherapy consisted of cyclophosphamide 1.7 g/m2 days 1-4, BCNU 150 mg/m2 days 1-4, etoposide 400 mg/m2 days 1-4. All patients transplanted with more than 5 × 106 CD34+ cells/kg had a rapid platelet recovery (20 × 109/l) between 6 and 11 days and neutrophil recovery (0.5 × 109/l) between 9 and 16 days, while patients transplanted with less than 5 × 106/kg had a delayed reconstitution, regardless of the kind of growth factor used for PBSC mobilization. In conclusion, our data indicate that in patients with Hodgkin’s disease G-CSF and GM-CSF given after salvage chemotherapy appear to be not different in their ability to mobilize PBSC resulting in a similar time needed for hematological reconstitution when autografted following high-dose therapy. 
650 4 |a Cell Biology 
650 4 |a general 
650 4 |a Hematology 
650 4 |a Internal Medicine 
650 4 |a Medicine/Public Health 
650 4 |a Public Health 
650 4 |a Stem Cells 
700 1 |a Martin, H.  |e VerfasserIn  |4 aut 
700 1 |a Waßmann, Barbara  |d 1967-  |e VerfasserIn  |0 (DE-588)113723156  |0 (DE-627)543648206  |0 (DE-576)289772443  |4 aut 
700 1 |a Egerer, Gerlinde  |e VerfasserIn  |0 (DE-588)105502168X  |0 (DE-627)792516745  |0 (DE-576)167430882  |4 aut 
700 1 |a Haus, U.  |e VerfasserIn  |4 aut 
700 1 |a Färber, L.  |e VerfasserIn  |4 aut 
700 1 |a Burger, K. J.  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Hoelzer, D.  |e VerfasserIn  |4 aut 
700 1 |a Haas, Rainer  |d 1955-  |e VerfasserIn  |0 (DE-588)173773524  |0 (DE-627)698678141  |0 (DE-576)134613805  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 22(1998), 7, Seite 625-630  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells 
773 1 8 |g volume:22  |g year:1998  |g number:7  |g pages:625-630  |g extent:6  |a Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells 
856 4 0 |u https://doi.org/10.1038/sj.bmt.1701422  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/1701422  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250423 
994 |a 1998 
998 |g 173773524  |a Haas, Rainer  |m 173773524:Haas, Rainer  |d 910000  |d 910100  |e 910000PH173773524  |e 910100PH173773524  |k 0/910000/  |k 1/910000/910100/  |p 10  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 105502168X  |a Egerer, Gerlinde  |m 105502168X:Egerer, Gerlinde  |d 910000  |d 910100  |e 910000PE105502168X  |e 910100PE105502168X  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1084809745  |a Hohaus, Stefan  |m 1084809745:Hohaus, Stefan  |d 910000  |d 910100  |e 910000PH1084809745  |e 910100PH1084809745  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1923462318  |e 4708501471 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Hohaus","display":"Hohaus, Stefan","role":"aut","given":"Stefan"},{"given":"H.","role":"aut","display":"Martin, H.","family":"Martin"},{"display":"Waßmann, Barbara","family":"Waßmann","given":"Barbara","role":"aut"},{"given":"Gerlinde","role":"aut","family":"Egerer","display":"Egerer, Gerlinde"},{"given":"U.","role":"aut","family":"Haus","display":"Haus, U."},{"role":"aut","given":"L.","display":"Färber, L.","family":"Färber"},{"role":"aut","given":"K. J.","family":"Burger","display":"Burger, K. J."},{"display":"Goldschmidt, Hartmut","family":"Goldschmidt","role":"aut","given":"Hartmut"},{"given":"D.","role":"aut","family":"Hoelzer","display":"Hoelzer, D."},{"family":"Haas","display":"Haas, Rainer","role":"aut","given":"Rainer"}],"language":["eng"],"note":["Gesehen am 23.04.2025"],"origin":[{"dateIssuedDisp":"09 October 1998","dateIssuedKey":"1998"}],"title":[{"title":"Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells","title_sort":"Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["S. Hohaus, H. Martin, B. Wassmann, G. Egerer, U. Haus, L. Färber, K.J. Burger, H. Goldschmidt, D. Hoelzer, and R. Haas"]},"physDesc":[{"extent":"6 S."}],"recId":"1923462318","relHost":[{"id":{"eki":["320433366"],"zdb":["2004030-1"],"issn":["1476-5365"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320433366","disp":"Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cellsBone marrow transplantation","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 17.01.25"],"origin":[{"dateIssuedKey":"1997","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke ; London"}],"pubHistory":["Nachgewiesen 19.1997 -"],"title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}],"part":{"pages":"625-630","year":"1998","text":"22(1998), 7, Seite 625-630","issue":"7","volume":"22","extent":"6"},"language":["eng"]}],"id":{"doi":["10.1038/sj.bmt.1701422"],"eki":["1923462318"]}} 
SRT |a HOHAUSSTEFRECOMBINAN0919